| Exchange | Price | % Move |
|---|---|---|
| CSE:EXM | ||
| FSE:A2PAW2 |
-
Landmark COVID Research Grant awarded by the European Union - Research Team focused on finding solutions to real-world issues
Learn More -
Johnathan Summers interview with Richard Zwicky on Cannabis Radio to discuss how EXMceuticals is climbing towards 'The Green Peak'.
Learn More -
Biosciences company with expertise in cannabinoid
Learn More -
Research Team focused on finding solutions to real-world issues
Learn More -
We are targeting the medical and legal 200bn USD global cannabis market estimated for 2028
Learn More
Pharma company that focuses on cannabis
EXMceuticals (“EXM”) is a medical cannabis company that strongly believes in the potential health and wellness benefits of hemp and cannabis. EXM is an emerging player in the market, with ambition and potential to become one of the world's suppliers of highest-grade cannabis ingredients. EXM is currently creating an industrial-scale, GMP, Pharmaceutical Grade Extraction and Refining facility inside the European Union, near Lisbon Portugal. EXM has an existing and licensed cannabis R&D facility and pilot refinery in Lisbon Portugal. EXM is targeting the B2B marketplace and will supply pure ingredients to the pharmaceutical, medicinal and wellness industry
Research Driven
Research-driven in cannabis extraction, distillation, purification and cannabinoid isolation with industry leading scientists
Innovation
Fully operational R&D laboratory in Portugal will now develop cannabis-based formulations for products and operate as a pilot-scale refinery for the transformation of cannabis-based ingredients.
Medical
Focused on providing the right ingredients to consumer goods infused products, capsules and oils for the medicinal and wellness industry.
Flexible Revenue Model
Our state-of-the-art testing lab is equipped to conduct all quality control testing for third parties. Processing Services to transform biomass or oil into high-grade extracts and white labelling services in the creation of custom extracts for specific product formulations.
Updates
Research and Development
EXMceuticals's fully operational R&D laboratory in Portugal will now develop cannabis-based formulations for products and operate as a pilot-scale refinery ...
EXMceuticals obtains its research and development
EXMceuticals Portugal has obtained the authorization for cannabis research and development from INFARMED, the Portuguese National Authority of Medicines and ...
Investor information
EXMceuticals Inc. Sets its Sights firmly on the estimated €200 Billion value of the combined European and US cannabis market in 2028 .
Our Portuguese extraction and refinery hub will process the raw materials from GMP certified suppliers in both Portugal and Internationally. Portugal will serve as the gateway to distribute pure ingredients across Europe and into North America & Asia.
Our Landmark BioBlockCOVID Project Research Grant accelerates our activities in our lab and keep our team focus on finding solutions to a real-world issue.